👁️ The Big FDA Decision This Week

In partnership with

All your news. None of the bias.

Be the smartest person in the room by reading 1440! Dive into 1440, where 3.5 million readers find their daily, fact-based news fix. We navigate through 100+ sources to deliver a comprehensive roundup from every corner of the internet – politics, global events, business, and culture, all in a quick, 5-minute newsletter. It's completely free and devoid of bias or political influence, ensuring you get the facts straight.

Subscribe to 1440 today.

Did you know a psychedelic journey involves five distinct phases:

The journey begins with ingestion, with onset time ranging from 20 minutes to an hour.

The come-up follows, bringing physical and psychological sensations such as increased heart rate and altered perception.

The peak is marked by intense sensory experiences, hallucinations, and feelings of unity with the universe.

During the comedown, a sense of calm and introspection sets in, though some may feel tired or experience withdrawal.

Integration involves reflecting on the experience and applying insights to everyday life.

Gotta Blast 🚀:

• Psilera is making non-hallucinogenic psychedelics to treat mental illness.

• Congress comes together ahead of the big FDA decision for MDMA therapy.

• Oregon grants first psilocybin edible manufacturer license!

Quote of the Week 📖:

CHANGING MINDS🧠

Mind-Bending Medicine Without the Trip 🍄🫠

Chris Witowski and Jackie von Salm, both USF alumni, are on a mission to revolutionize mental health treatment through their company, Psilera.

They’re developing non-hallucinogenic psychedelics that offer the therapeutic benefits of these substances without the trippy parts of the medicine. They aim to make mental health treatments more accessible and effective.

Psilera’s first big project is PSIL-006, a non-hallucinogenic compound currently entering human trials to treat frontotemporal dementia (FTD).

This innovative approach could significantly impact the lives of those suffering from severe psychiatric issues and neurodegenerative disorders.

Von Salm and Witowski are also advocating for policy changes to make psychedelic research easier and more effective. Their efforts are paving the way for a new era in mental health treatment, with the potential to help countless individuals lead happier, healthier lives.

Stay on the lookout for their amazing work! This could be a great alternative for people who don’t want the full experience of psychedelic medicines but still want part of the magic for other reasons.

More in the Space 👁️

👁️ Clearmind showcases promising research at Psychedelic Medicine – Israel 2024.

👁️ New LSD microdosing trial in New Zealand focuses on late-stage cancer patients, aiming for 50% Māori participation.

MOVING THE NEEDLE🪡

Congress Pushes for Immediate FDA Approval of MDMA for PTSD 🤯

In a rare bipartisan move, 80 members of Congress are urging the FDA to consider MDMA-assisted therapy for PTSD. With the FDA decision due by August 11 (4 days away), the lawmakers' letters emphasize the urgent need for new treatments as veteran suicides rise.

They highlight the staggering statistic: 6,000 veterans die by suicide each year, totaling over 150,000 since 9/11.

Something needs to change. This is that something.

Despite concerns over trial integrity and safety data, the FDA recognizes the pressing need for better PTSD therapies.

Dr. Shereef Elnahal of the VA noted, "Current PTSD treatments would pale in comparison to preliminary results from MDMA-assisted therapy, if they’re able to be replicated."

The push for MDMA-assisted therapy has gained momentum, with both congressional and veteran support advocating for its approval. This decision could mark a pivotal shift in PTSD treatment, offering hope to millions of veterans and others affected by the disorder.

What do you think the decision will be?

More in the Space 👁️

👁️ Oregon grants first psilocybin edibles manufacturer license.

👁️ Naropa University unveils state-approved psilocybin facilitator training.

👁️ Boulder approves local guidelines for regulating psychedelic mushrooms.

👁️ Massachusetts bill proposes psychedelics working group for veterans

COMMUNITY PULSE 🌐

_{LET’S LEARN}

In support of the MDMA therapy decision this week, we want to bring awareness to the pressing issue of PTSD among veterans. PTSD, an anxiety disorder triggered by severe trauma, affects over 500,000 U.S. veterans since 9/11 wars and beyond.

This condition often results in paranoia, depression, insomnia, and social isolation, making everyday life a struggle.

Combat PTSD is particularly challenging to treat, and traditional methods have low success rates. This makes the FDA's upcoming decision on MDMA therapy crucial. Psychedelic medicines offer a promising new approach to alleviate the profound suffering of PTSD, potentially bringing much-needed relief to veterans and their families.

Information provided by Heroic Hearts Project

_{PODCASTS/VIDEOS:}

Get Lost in the Sauce

Healing Trauma with Psychedelics for Veterans and Pro Athletes

_{EVENTS/COURSES/RETREATS:}

Exploration of the Impact of Microdosing Psychedelic Substances on Menopausal Symptoms: A 12-Week Observational Study

Recruiting Participants

If you’re peri or postmenopausal and considering microdosing in your own time, please consider taking part in this important research. The study is observational, and will follow you for 12 weeks during your pre-planned microdosing regimen.

Click the link to find out more if you qualify👇

The Healing Power of Ayahuasca and Film

📅 Dates: TODAY, from 12:00-1:30pm PDT

Online

Join this insightful conversation with award-winning artist and filmmaker Maxi Cohen as she unveils the profound impact ayahuasca has had on her creative journey. Hear firsthand how this sacred medicine has transformed her life and fueled her passion for storytelling through the medium of film. Explore the inspiration behind her captivating films about ayahuasca (including the groundbreaking documentary From Shock to Awe, Ayahuasca Diaries and The Holy Give Me) and her latest project “A Movement in Water,” which deeply connects with her ayahuasca experiences. The forum will also examine her involvement with the Brazilian ayahuasca religion Santo Daime, highlighting cultural differences and filming experiences in Brazil and beyond.

Psychedelic Science Conference 2025

📅 Dates: June 16-20, 2025

Denver, CO

Right now presale tickets for the most anticipated and largest psychedelic event in the world are offering MAPS members, donors, and returning Psychedelic Science attendees the first chance and best rates on core conference passes. If you’re someone who is interested in psychedelics, has a business in the space, or want’s to find out more — you should check this out!

BEFORE WE GO😢

🍄 Thank you for reading and being a part of this psychedelic journey!

👁️ Are you a psychedelic therapist/coach, retreat center, or brand looking to elevate your content? PSYCHSPACE Creations is here to help. Book a consultation call with us today and let’s bring your vision to life!

👁️ Have a question or want to build a partnership? Message us! [email protected]